US Patent Issued to Idorsia Pharmaceuticals on Oct. 6 for "CCR6 receptor modulators" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,168, issued on Oct. 6, was assigned to Idorsia Pharmaceuticals Ltd (Allschwil, Switzerland).

"CCR6 receptor modulators" was invented by Oliver Allemann (Allschwil, Switzerland), Eva Caroff (Allschwil, Switzerland), Francis Hubler (Allschwil, Switzerland) and Emmanuel Meyer (Allschwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the prevention or treatment of e.g. inflammatory/autoimmune diseases/disorders and cancer."

The patent was filed on Oct. 25, 2022, under Application No. 18/704,588.

*For further information, inclu...